Welcome   Guest   [Login | Register] Sign in with Facebook Sign in with Google Sign in with Yahoo!
logoRelationalStocks.com
STOCK TICKER:
NovoCure Limited - Ordinary Shares   (ticker: NVCR)
Insiders' Indicator :          Sell          (Click Here For Details)
INSIDERS' Score: 35
0 100 35
BuySell
Latest 1 month: 0 133,777
Latest 6 Months: 0 1,338,918
52 Weeks: 0 2,606,592
Details Of Insider Trading Activities
TransactionCompanyTickerInsiderShares TradedAvg.
Price
Total ValueFiling
2020-01-17
Sale
NovoCure LtdNVCRDOYLE WILLIAM F
Executive Chairman, Director
133,777$95.00$12,708,815
2019-12-02
Sale
NovoCure LtdNVCRPHILLIPS CHARLES G III
Director
6,145$88.11$541,435
2019-11-25
Sale
NovoCure LtdNVCRLEUNG GABRIEL
Director
20,000$95.00$1,900,000
2019-11-25
Sale
NovoCure LtdNVCRDanziger Asaf
Chief Executive Officer, Director
103,000$95.00$9,785,000
2019-11-25
Sale
NovoCure LtdNVCRDOYLE WILLIAM F
Executive Chairman, Director
16,223$96.04$1,558,056
2019-11-20
Sale
NovoCure LtdNVCRDOYLE WILLIAM F
Executive Chairman, Director
150,000$90.36$13,554,000
2019-11-20
Sale
NovoCure LtdNVCRLEUNG GABRIEL
Director
20,000$90.00$1,800,000
2019-11-18
Sale
NovoCure LtdNVCRGROENHUYSEN WILHELMUS CM
Chief Financial Officer
5,832$85.99$501,493
2019-11-18
Sale
NovoCure LtdNVCRLEUNG GABRIEL
Director
10,000$85.00$850,000
2019-11-15
Sale
NovoCure LtdNVCRGROENHUYSEN WILHELMUS CM
Chief Financial Officer
20,000$83.25$1,665,000
2019-11-15
Sale
NovoCure LtdNVCRLEUNG GABRIEL
Director
10,000$83.24$832,400
2019-11-14
Sale
NovoCure LtdNVCRGROENHUYSEN WILHELMUS CM
Chief Financial Officer
27,576$81.87$2,257,647
2019-11-13
Sale
NovoCure LtdNVCRGROENHUYSEN WILHELMUS CM
Chief Financial Officer
40,000$80.87$3,234,800
2019-11-12
Sale
NovoCure LtdNVCRGROENHUYSEN WILHELMUS CM
Chief Financial Officer
40,000$80.17$3,206,800
2019-11-12
Sale
NovoCure LtdNVCRDOYLE WILLIAM F
Executive Chairman, Director
13,218$81.68$1,079,646
2019-11-11
Sale
NovoCure LtdNVCRGROENHUYSEN WILHELMUS CM
Chief Financial Officer
8,600$80.13$689,118
2019-11-11
Sale
NovoCure LtdNVCRDOYLE WILLIAM F
Executive Chairman, Director
29,782$80.11$2,385,836
2019-11-11
Sale
NovoCure LtdNVCRLEUNG GABRIEL
Director
5,000$79.57$397,849
2019-11-04
Sale
NovoCure LtdNVCRAmbrogi Michael J.
Chief Operating Officer
80,819$79.00$6,384,701
2019-10-10
Sale
NovoCure LtdNVCRLEUNG GABRIEL
Director
5,000$72.28$361,400
2019-09-24
Sale
NovoCure LtdNVCRGROENHUYSEN WILHELMUS CM
CFO
7,992$80.63$644,394
2019-09-16
Sale
NovoCure LtdNVCRGROENHUYSEN WILHELMUS CM
Chief Financial Officer
25,000$78.93$1,973,250
2019-09-13
Sale
NovoCure LtdNVCRGROENHUYSEN WILHELMUS CM
Chief Financial Officer
25,000$79.82$1,995,499
2019-09-12
Sale
NovoCure LtdNVCRGROENHUYSEN WILHELMUS CM
Chief Financial Officer
25,000$79.57$1,989,249
2019-09-11
Sale
NovoCure LtdNVCRGROENHUYSEN WILHELMUS CM
Chief Financial Officer
25,000$77.98$1,949,500
2019-09-10
Sale
NovoCure LtdNVCRGROENHUYSEN WILHELMUS CM
Chief Financial Officer
25,000$75.55$1,888,750
2019-09-10
Sale
NovoCure LtdNVCRLEUNG GABRIEL
Director
5,000$76.63$383,150
2019-09-09
Sale
NovoCure LtdNVCRGROENHUYSEN WILHELMUS CM
Chief Financial Officer
25,000$80.83$2,020,750
2019-09-03
Sale
NovoCure LtdNVCRLongsworth Todd Christopher
General Counsel
158,440$87.87$13,922,122
2019-08-30
Sale
NovoCure LtdNVCRPHILLIPS CHARLES G III
Director
22,000$91.14$2,005,080
2019-08-29
Sale
NovoCure LtdNVCRVERNON W ANTHONY
Director
100,000$91.03$9,103,000
2019-08-29
Sale
NovoCure LtdNVCRDanziger Asaf
Chief Executive Officer, Director
124,181$91.13$11,316,614
2019-08-12
Sale
NovoCure LtdNVCRLEUNG GABRIEL
Director
5,000$86.45$432,250
2019-08-02
Sale
NovoCure LtdNVCRShah Pritesh
Chief Commercial Officer
1,813$85.23$154,521
2019-08-01
Sale
NovoCure LtdNVCRShah Pritesh
Chief Commercial Officer
1,905$83.20$158,496
2019-07-31
Sale
NovoCure LtdNVCRShah Pritesh
Chief Commercial Officer
5,115$82.92$424,135

1 2 3 4 5 6 7 8 Next >

*Data and information is provided for informational purposes only, and is not intended for trading purposes.*
*By accessing the Relationalstocks.com web site, a user agrees that RelationalStocks.com shall be not liable for any errors or delays in the content.*